176 related articles for article (PubMed ID: 11798641)
1. [Renal protective effect of valsartan in diabetic rats].
Wen H; Lin S
Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):157-60. PubMed ID: 11798641
[TBL] [Abstract][Full Text] [Related]
2. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
4. [Losartan downregulates the expression of transforming growth factor beta type I and type II receptors in kidney of diabetic rat].
Guo ZX; Qiu MC
Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):403-8. PubMed ID: 12895325
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
[TBL] [Abstract][Full Text] [Related]
6. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
7. [Expression of type I transforming growth factor beta receptor in renal cortex in streptozotocin-induced diabetic rats and the regulation of benazepril].
Wu Y; Lin S
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):9-13. PubMed ID: 11798618
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
10. [Effects of simvastatin on TGF-beta system of diabetic rat kidneys].
Chen ZX; Lei MX; Zhu LF; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):593-6. PubMed ID: 16320597
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V, and transforming growth factor beta1 in the airway walls of sensitized rats.
Du YC; Xu JY; Zhang SJ
Chin Med J (Engl); 2004 Jun; 117(6):908-12. PubMed ID: 15198897
[TBL] [Abstract][Full Text] [Related]
13. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
Gong ZJ; Song SL; Huang YQ; Ruan P
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
[TBL] [Abstract][Full Text] [Related]
14. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
16. Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats.
Tang L; Yi R; Yang B; Li H; Chen H; Liu Z
Diabetes Res Clin Pract; 2012 Jul; 97(1):125-31. PubMed ID: 22377232
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Yuan J; Jia R; Bao Y
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
[TBL] [Abstract][Full Text] [Related]
18. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
19. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
